BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
11/3/2015 5:30:00 PM | Browse: 545 | Download: 734
Publication Name World Journal of Gastroenterology
Manuscript ID 18858
Country/Territory Russia
Received
2015-04-28 15:36
Peer-Review Started
2015-05-05 21:10
To Make the First Decision
2015-07-13 15:13
Return for Revision
2015-07-17 16:46
Revised
2015-08-14 20:45
Second Decision
2015-09-23 19:47
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2015-09-30 08:34
Articles in Press
2015-09-30 08:34
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2015-10-09 11:24
Publish the Manuscript Online
2015-11-03 17:31
ISSN 1007-9327 (print) and 2219-2840 (online)
Open Access Open-Access: This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright © The Author(s) 2015. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Oncology
Manuscript Type Topic Highlights
Article Title Second-line treatment of metastatic gastric cancer: Current options and future directions
Manuscript Source Invited Manuscript
All Author List Dheepak Kanagavel, Mikhail Fedyanin, Alexey Tryakin and Sergei Tjulandin
Funding Agency and Grant Number
Corresponding Author Sergei Tjulandin, Professor, Department of Clinical Pharmacology and Chemotherapy, N. N. Blokhin Russian Cancer Research Center, Kashirskoe Shosse 24, Moscow 115478, Russia. stjulandin@mail.ru
Key Words Metastatic gastric cancer; Second-line chemotherapy; Targeted therapy; Taxane; Irinotecan; Ramucirumab
Core Tip This systematic review has analyzed the currently available treatment options with chemotherapy and targeted agents in the second-line treatment of metastatic gastric cancer. In addition, this review has discussed the future directions of research and the prognostic factors that influence patient survival in those receiving second-line therapy for metastatic gastric cancer.
Publish Date 2015-11-03 17:31
Citation Kanagavel D, Fedyanin M, Tryakin A, Tjulandin S. Second-line treatment of metastatic gastric cancer: Current options and future directions. World J Gastroenterol 2015; 21(41): 11621-11635
Url http://www.wjgnet.com/1007-9327/full/v21/i41/11621.htm
DOI http://dx.doi.org/10.3748/wjg.v21.i41.11621
Full Article (PDF) WJG-21-11621.pdf
Full Article (Word) WJG-21-11621.doc
Manuscript File 18858-Review.docx
Answering Reviewers 18858-Answering reviewers.pdf
Audio Core Tip 18858-Audio core tip.mp3
Conflict-of-Interest Disclosure Form 18858-Conflict-of-interest statement.pdf
Copyright License Agreement 18858-Copyright assignment.pdf
Non-Native Speakers of English Editing Certificate 18858-Language certificate.pdf
Peer-review Report 18858-Peer-review(s).pdf
Scientific Misconduct Check 18858-Scientific misconduct check.pdf
Scientific Editor Work List 18858-Scientific editor work list.pdf